Integra LifeSciences Holdings (IART)

Receivables turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	1,486,360	1,506,670	1,533,950	1,298,690	1,461,480
Receivables	US$ in thousands	259,327	263,465	231,831	225,532	275,296
Receivables turnover		5.73	5.72	6.62	5.76	5.31

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $1,486,360K ÷ $259,327K
= 5.73

The receivables turnover ratio for Integra Lifesciences Holdings Corp has shown a slight fluctuation over the past five years. The ratio decreased from 5.51 in 2019 to 6.65 in 2021, indicating an improvement in collecting receivables efficiently. However, there was a slight decrease in the ratio in 2022 and 2023 to 5.91 and 5.94, respectively, suggesting a longer time taken to collect receivables in those years compared to 2021. Overall, the company's ability to collect receivables has been relatively stable, with the ratio ranging between 5.51 and 6.65 over the last five years.